An Immunophenotyping of Ovarian Cancer With Clinical and Immunological Significance

Immune checkpoint blockade (ICB), mainly anti-CTLA-4 and anti-PD-1/PD-L1 therapy, has showed promising clinical benefits in the treatment of some cancer types; however, its application in ovarian cancer is still in the primary stage. Immunophenotyping can help us understand the clinical characterist...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kai, Zhao, Weiwei, Lou, Ge, Rong, Zhiwei, Xu, Huan, Wang, Wenjie, Song, Wei, Cai, Yuqing, Hou, Yan, Li, Kang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394551/
https://www.ncbi.nlm.nih.gov/pubmed/32793247
http://dx.doi.org/10.3389/fimmu.2018.00757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394551/
https://www.ncbi.nlm.nih.gov/pubmed/32793247
http://dx.doi.org/10.3389/fimmu.2018.00757

Ejemplares similares